Ticker League

Abbott Laboratories (ABT) vs Johnson & Johnson (JNJ): Dividend Comparison

Side-by-side dividend metrics, income comparison, and growth analysis.

Side-by-Side Metrics

Johnson & Johnson (broad healthcare) vs Abbott (devices, diagnostics, nutrition). Two healthcare dividend staples—paired to contrast pharma-heavy cash flow vs medtech and nutrition mix.

  • MetricABTJNJ
  • CompanyAbbott LaboratoriesJohnson & Johnson
  • Income
  • Current Yield2.65%2.06%
  • FrequencyQuarterlyQuarterly
  • Safety
  • Payout Ratio67.97%61.65%
  • FCF covers dividendPassPass
  • No dividend cuts (10Y)PassPass
  • FCF Payout RatioPassPass
  • Net Debt / EBITDAPassPass
  • Div growth vs. EPS (5Y)FailPass
  • Growth
  • Div Growth (5Y CAGR)10.38%5.25%
  • Consecutive Growth Years1356
  • CCC classificationDividend ContenderDividend King
  • Context
  • Chowder score13.0%7.3%
  • Yield zone (vs 5Y avg)BUYSELL
  • Overall Score3 / 63 / 6
This analysis is for informational purposes only and is not financial advice. Safety scores and comparisons reflect historical data and do not predict future performance.

Income Comparison

How ABT and JNJ payouts compare on a $10,000 position — annual total, per-payment cash, and smoothed monthly equivalent.

MetricABTJNJ
Annual income$264.70$206.32
Payment frequencyQuarterly (4×/yr)Quarterly (4×/yr)
Per payment$66.17$51.58
Avg monthly$22.06$17.19

Dividend Growth

Historical compound annual growth of dividends per share. Bars use one scale across all periods.

Frequently asked questions

Comparison

Dividend comparisons — curated pairs

Browse more side-by-side dividend comparisons on popular stocks and Dividend Aristocrats

Explore

Abbott Laboratories (ABT) vs Johnson & Johnson (JNJ) Dividend Tools & Insights

Per-company dividend calculators and forecasts — click any row to explore.